chemXplore tracks 1 project in Kenya, of which one is active.
Of the active ones, 1 new construction.
Acquires former joint ventures in Zimbabwe, Zambia and Mozambique; gains controlling stakes in Kenya and Tanzania; transactions due early 2027; combined operations employ ~170 and generate ~€50m sales.
Guidance to help start Bundibugyo virus vaccine trials rapidly while maintaining safety: allows some animal-study waivers for known platforms, recommends early African trials, single-dose preference, and ring trial design.
700,000 b/d single‑train refinery in Kenya to come online faster by reusing proven designs, cutting development time by nearly two years; will make fuels and polypropylene and handle varied crudes.
LATA shows superiority in adolescents; OPERA real‑world suppression comparable to oral regimens; cabotegravir injections rated better than lenacapavir; EXTEND 4M tests 4‑month formulation.
Early, multi-faceted plan includes seven royalty‑free licenses covering 129 LMICs, regional manufacturing support in Africa and Latin America, and early manufacturing investment to speed availability.
USD 17–20bn single‑train coastal refinery tied to the 800 km Lokichar–Lamu pipeline; FEED not yet awarded; Kenya allocated KES 21.5bn in seed capital.
The project aims to improve occupational safety and social protection for agri-business workers in the Republic of Congo, building on success in Kenya and Côte d’Ivoire.
The new facility in Nairobi enhances blood safety and healthcare capacity in East Africa, offering training for local professionals and supporting Kenya's universal health coverage goals.
